Jia Su

Title: The Innovations of Jia Su

Introduction

Jia Su is an accomplished inventor based in Scarsdale, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, her work has the potential to impact medical treatments significantly.

Latest Patents

One of Jia Su's latest patents is focused on Anti-NPR1 antibodies and their uses. This invention provides monoclonal antibodies that specifically bind to the natriuretic peptide receptor 1 (NPR1) protein. The patent outlines various embodiments where the antibodies are fully human and can activate NPR1 activity. This innovation offers a promising approach to treating or preventing diseases, disorders, or conditions associated with NPR1 in humans.

Career Highlights

Jia Su is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work at Regeneron has positioned her as a key player in the biotechnology sector, contributing to groundbreaking innovations.

Collaborations

Jia has collaborated with notable colleagues, including Michael E. Dunn and Jason Mastaitis, enhancing her research through teamwork and shared expertise.

Conclusion

Jia Su's contributions to the field of biotechnology, particularly through her patents on Anti-NPR1 antibodies, showcase her innovative spirit and dedication to advancing medical science. Her work at Regeneron Pharmaceuticals, Inc. continues to pave the way for future breakthroughs in treatment options.